INMED PHARMACEUTICALS INC. Shareholders' Equity
INMED PHARMACEUTICALS INC. (INM) had Shareholders' Equity of $1.08 million as of 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-09
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.08M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.89M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.59M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $11.59M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $1.08M S-4/A · filed 2026-09-09 | |
| 2026-03-31 | $6.89M S-4 · filed 2026-07-02 | |
| 2025-12-31 | $9.59M S-4 · filed 2026-07-02 | |
| 2025-09-30 | $11.59M S-4 · filed 2026-07-02 | |
| 2025-06-30 | $13.43M S-4/A · filed 2026-09-09 | |
| 2025-03-31 | $7.02M S-4 · filed 2026-07-02 | |
| 2024-12-31 | $6.18M S-4 · filed 2026-07-02 | |
| 2024-09-30 | $8.40M S-4 · filed 2026-07-02 | |
| 2024-06-30 | $9.21M S-4/A · filed 2026-09-09 | |
| 2024-03-31 | $11.10M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $12.77M 10-Q · filed 2025-05-12 | |
| 2023-09-30 | -$9.58M 10-Q · filed 2025-05-12 | $9.58M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $12.09M S-4 · filed 2026-07-02 | |
| 2023-03-31 | $12.39M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $14.34M 10-Q · filed 2024-02-13 | |
| 2022-09-30 | $11.01M 10-Q · filed 2024-02-13 | |
| 2022-06-30 | $9.08M 10-K · filed 2024-09-30 | |
| 2022-03-31 | $10.89M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $14.17M 10-Q · filed 2023-05-15 | |
| 2021-09-30 | $15.22M 10-Q · filed 2023-02-17 | |
| 2021-06-30 | $7.38M 10-K · filed 2023-09-29 | |
| 2021-03-31 | $10.41M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $7.59M 10-Q · filed 2022-05-13 | |
| 2020-09-30 | $4.49M 10-Q · filed 2022-02-14 | |
| 2020-06-30 | $5.88M 10-K · filed 2022-09-23 | |
| 2020-03-31 | $7.07M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $9.61M 10-Q · filed 2021-05-13 | |
| 2019-09-30 | $11.47M 10-Q · filed 2021-02-11 | $11.47M 10-Q · filed 2020-12-17 |
| 2019-06-30 | $14.24M 10-K · filed 2021-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |